
Languages Spoken: English
Dr. Andrew Gawron is an Assistant Professor at the University of Utah and VA Medical Center. His clinical interests include treating patients with esophageal disease (gastroesophageal reflux disease, motility disorders such as achalasia, and eosinophilic esophagitis). He performs colonoscopy, upper endoscopy and interprets esophageal motility and pH studies.
Dr. Gawron completed his medical degree, internal medicine residency, and gastroenterology fellowship as chief fellow at Northwestern University in Chicago, IL. He received additional experience in diagnosing and treating esophageal disorders at Northwestern University where he served as a Clinical Instructor.
Dr. Gawron is board certified in Internal Medicine and Gastroenterology. He is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the International Society for Diseases of the Esophagus.
Clinical Locations
Gastroenterology Endoscopy Center
801-213-9797
Veterans Administration Medical Center
801-584-1236
Board Certification and Academic Information
Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
Academic Divisions | Gastroenterology |
Board Certification | American Board of Internal Medicine (Internal Medicine) American Board of Internal Medicine (Sub: Gastroenterology) |
Dr. Andrew Gawron is an Assistant Professor at the University of Utah and VA Medical Center. His clinical interests include treating patients with esophageal disease (gastroesophageal reflux disease, motility disorders such as achalasia, and eosinophilic esophagitis). He performs colonoscopy, upper endoscopy and interprets esophageal motility and pH studies.
Dr. Gawron completed his medical degree, internal medicine residency, and gastroenterology fellowship as chief fellow at Northwestern University in Chicago, IL. He received additional experience in diagnosing and treating esophageal disorders at Northwestern University where he served as a Clinical Instructor.
Dr. Gawron is board certified in Internal Medicine and Gastroenterology. He is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the International Society for Diseases of the Esophagus.
Academic Locations
Board Certification and Academic Information
Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
Academic Divisions | Gastroenterology |
Board Certification | American Board of Internal Medicine (Internal Medicine) American Board of Internal Medicine (Sub: Gastroenterology) |
Research Interests
- Esophageal Motility Disorders
- Esophageal Diseases
- Gastroesophageal Reflux Disease (GERD)
- Manometry
- Biomedical Informatics
Education History
Fellowship | Northwestern University Feinberg School of Medicine Chief Fellow, 2013 |
Graduate Training | Northwestern University Feinberg School of Medicine Health Services and Outcomes Research M.S., 2013 |
Research Fellow | Northwestern University Postdoctoral Research Fellow, 2013 |
Fellowship | McGaw Medical Center Gastroenterology, Hepatology, and Nutrition Fellow, 2013 |
Residency | McGaw Medical Center Internal Medicine Resident, 2009 |
Professional Medical | Northwestern University Feinberg School of Medicine Medicine M.D., 2007 |
Research Fellow | University of Nebraska Medical Center Postdoctoral Research Fellow, 2003 |
Doctoral Training | University of Kansas Pharmaceutical Chemistry Ph.D., 2001 |
Graduate Training | University of Kansas Pharmaceutical Chemistry M.S., 1999 |
Undergraduate | Truman State University Chemistry, English minor B.S., 1996 |
Selected Publications - Journal Articles
Journal Article
- Gawron AJ, Sultan S, Glorioso TJ, Califano S, Kralovic SM, Jones M, Kirsh S, Dominitz JA (2022). Pre-Endoscopy COVID-19 screening and SARS-CoV-2 nucleic acid amplification testing in the VA Healthcare System: Clinical practice patterns, outcomes, and relationship to procedure volume. Gastrointest Endosc.
- Keswani RN, Wood M, Benson M, Gawron AJ, Kahi C, Kaltenbach T, Yadlapati R, Gregory D, Duloy A (2022). Individualized feedback on colonoscopy skills improves group colonoscopy quality in providers with lower adenoma detection rates. Endosc Int Open, 10(3), E232-E237.
- Gawron AJ, Yao Y, Gupta S, Cole G, Whooley MA, Dominitz JA, Kaltenbach T (2020). Simplifying Measurement of Adenoma Detection Rates for Colonoscopy. Dig Dis Sci, 66(9), 3149-3155.
- Keswani RN, Kahi CJ, Benson M, Gawron AJ, Kaltenbach TR, Yadlapati RH, Gregory DL, Duloy A (2021). Cecal retroflexion is infrequently performed in routine practice and the retroflexed view is of poor quality. BMC Gastroenterol, 21(1), 307.
- McKenzie P, Fang J, Davis J, Qiu Y, Zhang Y, Adler DG, Gawron AJ (2020). Safety of endoscopist-directed nurse-administered balanced propofol sedation in patients with severe systemic disease (ASA class III). Gastrointest Endosc, 94(1), 124-130.
- Gawron AJ, Staub J, Bielefeldt K (2020). Impact of Health Insurance, Poverty, and Comorbidities on Colorectal Cancer Screening: Insights from the Medical Expenditure Panel Survey. Dig Dis Sci, 66(1), 70-77.
- Gawron AJ, Kaltenbach T, Dominitz JA (2020). The Impact of the Coronavirus Disease-19 Pandemic on Access to Endoscopy Procedures in the VA Healthcare System. Gastroenterology, 159(4), 1216-1220.e1.
- DeLay K, Pandolfino JE, Gyawali CP, Frye J, Kaizer A, Menard-Katcher P, Sloan JA, Gawron AJ, Peterson K, Carlson DA, Khan A, Keswani RN, Yadlapati R (2020). Esophageal Manometry Competency Program Improves Gastroenterology Fellow Performance in Motility Interpretation. Am J Gastroenterol, 115(9), 1453-1459.
- Low EE, Demb J, Liu L, Earles A, Bustamante R, Williams CD, Provenzale D, Kaltenbach T, Gawron AJ, Martinez ME, Gupta S (2020). Risk Factors for Early-Onset Colorectal Cancer. Gastroenterology, 159(2), 492-501.e7.
- Gawron AJ, Bell R, Abu Dayyeh BK, Buckley FP, Chang K, Dunst CM, Edmundowicz SA, Jobe B, Lipham JC, Lister D, Canto MI, Smith MS, Starpoli AA, Triadafilopoulos G, Watson TJ, Wilson E, Pandolfino JE, Kaizer A, Van De Voorde Z, Yadlapati R (2020). Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel. Gastrointest Endosc, 92(1), 78-87.e2.
- Shah SC, Gawron AJ, Li D (2020). Surveillance of Gastric Intestinal Metaplasia. Am J Gastroenterol, 115(5), 641-644.
- Keswani RN, Benson M, Beveridge C, Gawron AJ, Gluskin AB, Kahi CJ, Kaltenbach TR, McClure J, Schenck R, Yadlapati RH, Duloy A (2019). Colonoscopy-Naïve Raters Can Be Trained to Assess Colonoscopy Quality. Clin Gastroenterol Hepatol, 18(4), 989-991.e1.
- Altayar O, Davitkov P, Shah SC, Gawron AJ, Morgan DR, Turner K, Mustafa RA (2019). AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Gastroenterology, 158(3), 732-744.e16.
- Davitkov P, Altayar O, Shah SC, Gawron AJ, Mustafa RA, Sultan S, Morgan DR (2019). Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations. Gastroenterology, 158(3), 751-759.
- Shah SC, Gawron AJ, Mustafa RA, Piazuelo MB (2019). Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. Gastroenterology, 158(3), 745-750.
- Shah SC, Gupta S, Li D, Morgan D, Mustafa RA, Gawron AJ (2020). Spotlight: Gastric Intestinal Metaplasia. Gastroenterology, 158(3), 704.
- Demb J, Yaseyyedi A, Liu L, Bustamante R, Earles A, Ghosh P, Gutkind JS, Gawron AJ, Kaltenbach TR, Martinez ME, Gupta S (2019). Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes. Clin Transl Gastroenterol, 10(11), e00092.
- Bustamante R, Earles A, Murphy JD, Bryant AK, Patterson OV, Gawron AJ, Kaltenbach T, Whooley MA, Fisher DA, Saini SD, Gupta S, Liu L (2019). Ascertainment of Aspirin Exposure Using Structured and Unstructured Large-scale Electronic Health Record Data. Med Care, 57(10), e60-e64.
- Gawron A, Bielefeldt K (2019). Unrelated Death After Colorectal Cancer Screening: Implications for Improving Colonoscopy Referrals. Fed Pract, 36(6), 262-270.
- McVay TR, Garrett G C, Celena B P, Klaus B, Fang JC, Chapman WW, Samore MH, Gawron AJ (2019). Natural Language Processing Accurately Identifies Dysphagia Indications for Esophagogastroduodenoscopy Procedures in a Large US Integrated Healthcare System: Implications for Classifying Overuse and Quality Measurement. AMIA Jt Summits Transl Sci Proc, 2019, 665-671.
- Patel J, Fang J, Taylor LJ, Adler DG, Gawron AJ (2019). Safety and efficacy of non-anesthesiologist administration of propofol sedation during esophagogastroduodenoscopy in the intensive care unit. Endosc Int Open, 7(4), E625-E629.
- Earles A, Liu L, Bustamante R, Coke P, Lynch J, Messer K, Martnez ME, Murphy JD, Williams CD, Fisher DA, Provenzale DT, Gawron AJ, Kaltenbach T, Gupta S (2019). Structured Approach for Evaluating Strategies for Cancer Ascertainment Using Large-Scale Electronic Health Record Data. JCO Clin Cancer Inform, 2, 1-12.
- Gawron AJ, Lawrence P, Millar MM, Dominitz JA, Gupta S, Whooley M, Kaltenbach T (2019). A Nationwide Survey and Needs Assessment of Colonoscopy Quality Assurance Programs in the VA. Fed Pract, 35(3), 26-32.
- Balbale S, Gawron A, LaVela SL (2019). Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy. Patient Exp J, 5(3), 149-159.
- Gawron AJ, Pandolfino JE, Howden CE (2014). Initial proton pump inhibitor prescription characteristics associated with long-term use in US Veterans diagnosed with gastroesophageal reflux disease. J Pharm Health Serv Res, 5(3), 157-164.